# Phase IIa Safety and Efficacy Study of SPP635 in Mild to Moderate Hypertension

> **NCT00376636** · PHASE2 · COMPLETED · sponsor: **Speedel Pharma Ltd.** · enrollment: 35 (actual)

## Conditions studied

- Hypertension

## Interventions

- **DRUG:** SPP635 (drug)

## Key facts

- **NCT ID:** NCT00376636
- **Lead sponsor:** Speedel Pharma Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-10
- **Primary completion:** —
- **Final completion:** 2007-05
- **Target enrollment:** 35 (ACTUAL)
- **Last updated:** 2007-10-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00376636

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00376636, "Phase IIa Safety and Efficacy Study of SPP635 in Mild to Moderate Hypertension". Retrieved via AI Analytics 2026-07-01 from https://api.ai-analytics.org/clinical/NCT00376636. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*